309 related articles for article (PubMed ID: 30795770)
41. Case report: The spectrum of SMPD1 pathogenic variants in Hungary.
Molnar MJ; Szlepak T; Csürke I; Loth S; Káposzta R; Erdős M; Dezsőfi A
Front Genet; 2023; 14():1158108. PubMed ID: 37347058
[TBL] [Abstract][Full Text] [Related]
42. The Genetic Basis, Lung Involvement, and Therapeutic Options in Niemann-Pick Disease: A Comprehensive Review.
Tirelli C; Rondinone O; Italia M; Mira S; Belmonte LA; De Grassi M; Guido G; Maggioni S; Mondoni M; Miozzo MR; Centanni S
Biomolecules; 2024 Feb; 14(2):. PubMed ID: 38397448
[TBL] [Abstract][Full Text] [Related]
43. Modulation of Dietary Choline Uptake in a Mouse Model of Acid Sphingomyelinase Deficiency.
Gaudioso Á; Moreno-Huguet P; Casas J; Schuchman EH; Ledesma MD
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298714
[TBL] [Abstract][Full Text] [Related]
44. Highly variable neural involvement in sphingomyelinase-deficient Niemann-Pick disease caused by an ancestral Gypsy mutation.
Mihaylova V; Hantke J; Sinigerska I; Cherninkova S; Raicheva M; Bouwer S; Tincheva R; Khuyomdziev D; Bertranpetit J; Chandler D; Angelicheva D; Kremensky I; Seeman P; Tournev I; Kalaydjieva L
Brain; 2007 Apr; 130(Pt 4):1050-61. PubMed ID: 17360762
[TBL] [Abstract][Full Text] [Related]
45. Identification of a distinct mutation spectrum in the SMPD1 gene of Chinese patients with acid sphingomyelinase-deficient Niemann-Pick disease.
Zhang H; Wang Y; Gong Z; Li X; Qiu W; Han L; Ye J; Gu X
Orphanet J Rare Dis; 2013 Jan; 8():15. PubMed ID: 23356216
[TBL] [Abstract][Full Text] [Related]
46. Identification and characterization of eight novel SMPD1 mutations causing types A and B Niemann-Pick disease.
Desnick JP; Kim J; He X; Wasserstein MP; Simonaro CM; Schuchman EH
Mol Med; 2010; 16(7-8):316-21. PubMed ID: 20386867
[TBL] [Abstract][Full Text] [Related]
47. Olipudase Alfa in Non-CNS Manifestations of Acid Sphingomyelinase Deficiency: A Profile of Its Use.
Syed YY
Clin Drug Investig; 2023 May; 43(5):369-377. PubMed ID: 37133675
[TBL] [Abstract][Full Text] [Related]
48. Acid sphingomyelinase: identification of nine novel mutations among Italian Niemann Pick type B patients and characterization of in vivo functional in-frame start codon.
Pittis MG; Ricci V; Guerci VI; Marçais C; Ciana G; Dardis A; Gerin F; Stroppiano M; Vanier MT; Filocamo M; Bembi B
Hum Mutat; 2004 Aug; 24(2):186-7. PubMed ID: 15241805
[TBL] [Abstract][Full Text] [Related]
49. A retrospective study of morbidity and mortality of chronic acid sphingomyelinase deficiency in Germany.
Mengel E; Muschol N; Weinhold N; Ziagaki A; Neugebauer J; Antoni B; Langer L; Gasparic M; Guillonneau S; Fournier M; Laredo F; Pulikottil-Jacob R
Orphanet J Rare Dis; 2024 Apr; 19(1):161. PubMed ID: 38615062
[TBL] [Abstract][Full Text] [Related]
50. Types A and B Niemann-Pick Disease.
Schuchman EH; Wasserstein MP
Pediatr Endocrinol Rev; 2016 Jun; 13 Suppl 1():674-81. PubMed ID: 27491215
[TBL] [Abstract][Full Text] [Related]
51. Successful within-patient dose escalation of olipudase alfa in acid sphingomyelinase deficiency.
Wasserstein MP; Jones SA; Soran H; Diaz GA; Lippa N; Thurberg BL; Culm-Merdek K; Shamiyeh E; Inguilizian H; Cox GF; Puga AC
Mol Genet Metab; 2015; 116(1-2):88-97. PubMed ID: 26049896
[TBL] [Abstract][Full Text] [Related]
52. The Long-term Lung and Respiratory Outcomes of Acid Sphingomyelinase Deficiency: A 10- and 20-year Follow-up Study.
Huang YN; Chiang SL; Huang JY; Lu WL; Bau DT; Su PH; Wang CH
In Vivo; 2024; 38(1):437-444. PubMed ID: 38148059
[TBL] [Abstract][Full Text] [Related]
53. Olipudase alfa for treatment of acid sphingomyelinase deficiency (ASMD): safety and efficacy in adults treated for 30 months.
Wasserstein MP; Diaz GA; Lachmann RH; Jouvin MH; Nandy I; Ji AJ; Puga AC
J Inherit Metab Dis; 2018 Sep; 41(5):829-838. PubMed ID: 29305734
[TBL] [Abstract][Full Text] [Related]
54. Subclinical course of adult visceral Niemann-Pick type C1 disease. A rare or underdiagnosed disorder?
Dvorakova L; Sikora J; Hrebicek M; Hulkova H; Bouckova M; Stolnaja L; Elleder M
J Inherit Metab Dis; 2006 Aug; 29(4):591. PubMed ID: 16802107
[TBL] [Abstract][Full Text] [Related]
55. Sphingomyelin 16:0 is a therapeutic target for neuronal death in acid sphingomyelinase deficiency.
Gaudioso Á; Jiang X; Casas J; Schuchman EH; Ledesma MD
Cell Death Dis; 2023 Apr; 14(4):248. PubMed ID: 37024473
[TBL] [Abstract][Full Text] [Related]
56. Acid Sphingomyelinase Deficiency: Sharing Experience of Disease Monitoring and Severity in France.
Mauhin W; Borie R; Dalbies F; Douillard C; Guffon N; Lavigne C; Lidove O; Brassier A
J Clin Med; 2022 Feb; 11(4):. PubMed ID: 35207195
[TBL] [Abstract][Full Text] [Related]
57. Niemann-Pick type A disease with new mutation: a case report.
Aghamahdi F; Nirouei M; Savad S
J Med Case Rep; 2022 Jul; 16(1):288. PubMed ID: 35883096
[TBL] [Abstract][Full Text] [Related]
58. Biochemical and imaging parameters in acid sphingomyelinase deficiency: Potential utility as biomarkers.
Eskes ECB; Sjouke B; Vaz FM; Goorden SMI; van Kuilenburg ABP; Aerts JMFG; Hollak CEM
Mol Genet Metab; 2020 May; 130(1):16-26. PubMed ID: 32088119
[TBL] [Abstract][Full Text] [Related]
59. Olipudase alfa enzyme replacement therapy for acid sphingomyelinase deficiency (ASMD): sustained improvements in clinical outcomes after 6.5 years of treatment in adults.
Lachmann RH; Diaz GA; Wasserstein MP; Armstrong NM; Yarramaneni A; Kim Y; Kumar M
Orphanet J Rare Dis; 2023 Apr; 18(1):94. PubMed ID: 37098529
[TBL] [Abstract][Full Text] [Related]
60. Studies on the activation of sphingomyelinase activity in Niemann-Pick type A, B, and C fibroblasts: enzymological differentiation of types A and B.
Poulos A; Ranieri E; Shankaran P; Callahan JW
Pediatr Res; 1984 Nov; 18(11):1088-93. PubMed ID: 6096798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
